3.0.0 511 2022-02-03T05:25:28Z 2022-02-03T05:25:28Z Senate S S 2005-03-03 109 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2005-03-03T20:42:20Z RU-486 Suspension and Review Act of 2005 109 1079 HR 2005-03-14 Referred to the Subcommittee on Health. Related bill CRS 2005-03-03 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2020-2021) IntroReferral 2005-03-03 Sponsor introductory remarks on measure. (CR S2020) IntroReferral B00100 9 Library of Congress 2005-03-03 Introduced in Senate IntroReferral 10000 9 Library of Congress D000595 Sen. DeMint, Jim [R-SC] James DeMint R SC W. N A000121 Sen. Allen, George [R-VA] GEORGE ALLEN R VA F. 2005-03-03 True B000953 Sen. Brownback, Sam [R-KS] SAM BROWNBACK R KS 2005-03-03 True C000560 Sen. Coburn, Tom [R-OK] TOM COBURN R OK 2005-03-03 True E000194 Sen. Ensign, John [R-NV] JOHN ENSIGN R NV 2005-03-03 True E000285 Sen. Enzi, Michael B. [R-WY] MICHAEL ENZI R WY B. 2005-03-03 True I000024 Sen. Inhofe, James M. [R-OK] Jim Inhofe R OK 2005-03-03 True S000059 Sen. Santorum, Rick [R-PA] RICK SANTORUM R PA 2005-03-03 True V000127 Sen. Vitter, David [R-LA] David Vitter R LA 2005-03-03 True B001066 Sen. Bunning, Jim [R-KY] JIM BUNNING R KY 2005-07-11 False T000250 Sen. Thune, John [R-SD] John Thune R SD R. 2005-09-07 False D000294 Sen. DeWine, Mike [R-OH] MICHAEL DEWINE R OH 2005-09-21 False M001162 Sen. Martinez, Mel [R-FL] Mel Martinez R FL 2006-05-02 False Health Abortion Administrative procedure Commerce Congress Congressional investigations Congressional reporting requirements Congressional veto Department of Health and Human Services Drug approvals Drugs Food and Drug Administration (FDA) Government Operations and Politics Government publicity Labeling Law Health 00 2005-03-03 Introduced in Senate 2005-04-13T15:19:24Z RU-486 Suspension and Review Act of 2005 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been withdrawn.

Deems the drug misoprostol as misbranded under the Federal Food, Drug, and Cosmetic Act (FFDCA) if it bears labeling providing that the drug may be used for the medical termination of intrauterine pregnancy.

Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the reinstatement of the approved application for such drug if the report determines the approval to have been in accordance with FFDCA.

]]> RU-486 Suspension and Review Act of 2005 Short Titles as Introduced RU-486 Suspension and Review Act of 2005 Display Title RU-486 Suspension and Review Act of 2005 Official Title as Introduced A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug commonly known as RU-486 is deemed to have been withdrawn, to provide for the review by the Comptroller General of the United States of the process by which the Food and Drug Administration approved such drug, and for other purposes. Introduced in Senate 2005-03-03T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109s511is/xml/BILLS-109s511is.xml 2005-03-03 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2020-2021) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.